Columbus-based OhioHealth is piloting an AI-driven alert system to improve detection and treatment timelines for heart valve disease.
The tool, evaluated in the ALERT trial, sends real-time notifications to physicians based on echocardiogram results, identifying patients who may need further heart and vascular evaluation, according to a May 4 hospital news release.
The study, conducted across five academic and community-based health systems, found patients were more likely to be referred to specialists sooner and undergo procedures within 90 days.
The AI system is designed to support physician decision-making by flagging potential cases for review rather than directing care. OhioHealth said the approach targets earlier identification of conditions such as severe aortic stenosis and mitral regurgitation to improve outcomes.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
